Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers
Inge Mick(Imperial College London), Anne Lingford‐Hughes(Hammersmith Hospital), José Carlos Fernandes Galduróz(Universidade Federal de São Paulo), Mark C. Parkin(King's College London), Graham E. Searle(Unknown), David Nutt(Imperial College London), Anna Carolina Ramos(Imperial College London), Henrietta Bowden‐Jones(Southwestern Medical Center), David Erritzøe(Imperial College London), Alan D. Brailsford(King's College London), Adam Waldman(Royal Society of Edinburgh), Roger N. Gunn(Mitsubishi Corporation (United Kingdom)), Alessandro Colasanti(Imperial College London), Paul Stokes(King's College London), Luke Clark(University of British Columbia), Jim Myers(Imperial College London), Eugenii A. Rabiner(GlaxoSmithKline (United Kingdom))
Cited by 111
Related Papers
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
|Psychopharmacology|2017|969
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Amphetamine, past and present – a pharmacological and clinical perspective
|Journal of Psychopharmacology|2013|614